Related references
Note: Only part of the references are listed.Polyanhydride microparticles enhance dendritic cell antigen presentation and activation
Maria P. Torres et al.
ACTA BIOMATERIALIA (2011)
Follicular Helper CD4 T Cells (T-FH)
Shane Crotty
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Liposomal vaccine delivery systems
Malou Henriksen-Lacey et al.
EXPERT OPINION ON DRUG DELIVERY (2011)
Safety of BLP25 Liposome Vaccine (L-BLP25) in Japanese Patients with Unresectable Stage III NSCLC after Primary Chemoradiotherapy: Preliminary Results from a Phase I/II Study
Fumiyoshi Ohyanagi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2011)
Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial
Charles Butts et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Modulation of CD4+T Lymphocyte Lineage Outcomes with Targeted, Nanoparticle-Mediated Cytokine Delivery
Jason Park et al.
MOLECULAR PHARMACEUTICS (2011)
Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses
James J. Moon et al.
NATURE MATERIALS (2011)
Bio-inspired, bioengineered and biomimetic drug delivery carriers
Jin-Wook Yoo et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Design of a Protective Single-Dose Intranasal Nanoparticle-Based Vaccine Platform for Respiratory Infectious Diseases
Bret D. Ulery et al.
PLOS ONE (2011)
Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines
Stacey L. Demento et al.
TRENDS IN BIOTECHNOLOGY (2011)
Intratumoral delivery of encapsulated IL-12, IL-18 and TNF-α in a model of metastatic breast cancer
Michael S. Sabel et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
A Multicenter Open-Label Study to Assess the Safety of a New Formulation of BLP25 Liposome Vaccine in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer
Charles Butts et al.
CLINICAL LUNG CANCER (2010)
TLR9-Targeted Biodegradable Nanoparticles as Immunization Vectors Protect against West Nile Encephalitis
Stacey L. Demento et al.
JOURNAL OF IMMUNOLOGY (2010)
Therapeutic cell engineering with surface-conjugated synthetic nanoparticles
Matthias T. Stephan et al.
NATURE MEDICINE (2010)
Strategies in the design of nanoparticles for therapeutic applications
Robby A. Petros et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6
Wenda Gao et al.
CELL CYCLE (2009)
IL-12 delivered intratumorally by multilamellar liposomes reactivates memory T cells in human tumor microenvironments
Michelle R. Simpson-Abelson et al.
CLINICAL IMMUNOLOGY (2009)
Polymersome carriers: From self-assembly to siRNA and protein therapeutics
David A. Christian et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Liposome-based cationic adjuvant formulations (CAF): Past, present, and future
Dennis Christensen et al.
JOURNAL OF LIPOSOME RESEARCH (2009)
Interleukin-2: Evaluation of Routes of Administration and Current Delivery Systems in Cancer Therapy
Mohamed A. Shaker et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
A comprehensive platform for ex vivo T-cell expansion based on biodegradable polymeric artificial antigen-presenting cells
Erin R. Steenblock et al.
MOLECULAR THERAPY (2008)
L-BLP25: a MUC1-targeted peptide vaccine therapy in prostate cancer
Randeep Sangha et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Synergistic effect of intratumoral IL-12 and TNF-α microspheres:: systemic anti-tumor immunity is mediated by both CD8+ CTL and NK cells
Michael S. Sabel et al.
SURGERY (2007)
L-BLP25: A peptide vaccine strategy in non-small cell lung cancer
Randeep Sangha et al.
CLINICAL CANCER RESEARCH (2007)
Polymeric protein delivery systems
Kuen Yong Lee et al.
PROGRESS IN POLYMER SCIENCE (2007)
A novel proteoliposomal vaccine elicits potent antitumor immunity in mice
Mircea C. Popescu et al.
BLOOD (2007)
A novel proteoliposomal vaccine induces antitumor immunity against follicular lymphoma
Sattva S. Neelapu et al.
BLOOD (2007)
Gamma interferon loaded onto albumin nanoparticles:: In vitro and in vivo activities against Brucella abortus
S. Segura et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
The germinal center response is impaired in the absence of T cell-expressed CXCR5
Carrie N. Arnold et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Novel approaches in microparticulate PLGA delivery systems encapsulating proteins
Ajay Taluja et al.
JOURNAL OF MATERIALS CHEMISTRY (2007)
Neoadjuvant intratumoral cytokine-loaded microspheres are superior to postoperative autologous cellular vaccines in generating systemic anti-tumor immunity
Alisha Arora et al.
JOURNAL OF SURGICAL ONCOLOGY (2006)
New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now?
Si-Shen Feng
NANOMEDICINE (2006)
Enhanced immunogenicity and protective efficacy with the use of interleukin-12-encapsulated microspheres plus AS01B in tuberculosis subunit vaccination
Sang-Jun Ha et al.
INFECTION AND IMMUNITY (2006)
Development and characterization of interleukin-18-loaded biodegradable microspheres
F. Lagarce et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Interleukin-2/liposomes potentiate immune responses to a soluble protein cancer vaccine in mice
D Johnston et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Novel nonviral delivery approaches for interleukin-12 protein and gene systems: Curbing toxicity and enhancing adjuvant activity
Mohamed Labib Salem et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2006)
Tumor necrosis factor (TNF)-functionalized nanostructured particles for the stimulation of membrane TNF-Specific cell responses
S Bryde et al.
BIOCONJUGATE CHEMISTRY (2005)
Recent advances with liposomes as pharmaceutical carriers
VP Torchilin
NATURE REVIEWS DRUG DISCOVERY (2005)
Human CD4+ effector memory T cells persisting in the microenvironment of lung cancer xenografts are activated by local delivery of IL-12 to proliferate, produce IFN-γ, and eradicate tumor cells
L Broderick et al.
JOURNAL OF IMMUNOLOGY (2005)
Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function
R Zeng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Intratumoral IL-12 and TNF-α-loaded microspheres lead to regression of breast cancer and systemic antitumor immunity
MS Sabel et al.
ANNALS OF SURGICAL ONCOLOGY (2004)
Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen
SS Neelapu et al.
CLINICAL CANCER RESEARCH (2004)
Characterization of cytokine-encapsulated controlled-release microsphere adjuvants
A Sharma et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2004)
Mircoparticlulate formulations for the controlled release of interleukin-2
TT Thomas et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
IL-2 loaded dextran microspheres with attractive histocompatibility properties for local IL-2 cancer therapy
JW Koten et al.
CYTOKINE (2003)
Immunogenicity and safety of a novel IL-2-supplemented liposomal influenza vaccine (INFLUSOME-VAC) in nursing-home residents
A Ben-Yehuda et al.
VACCINE (2003)
Immunogenicity and safety of a novel liposomal influenza subunit vaccine (INFLUSOME-VAC) in young adults
A Ben-Yehuda et al.
JOURNAL OF MEDICAL VIROLOGY (2003)
Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: A novel treatment for experimental malignant glioma
LD Rhines et al.
NEUROSURGERY (2003)
Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha
A Sánchez et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Human CD4(+) T cells present within the microenvironment of human lung tumors are mobilized by the local and sustained release of IL-12 to kill tumors in situ by indirect effects of IFN-gamma
SD Hess et al.
JOURNAL OF IMMUNOLOGY (2003)
Protection against plague following immunisation with microencapsulated V antigen is reduced by co-encapsulation with IFN-γ or IL-4, but not IL-6
KF Griffin et al.
VACCINE (2002)
Interferon-gamma therapy: Evaluation of routes of administration and delivery systems
HM Younes et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
Pegylated liposomal tumor necrosis factor-alpha results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil (R)) in soft tissue sarcoma-bearing rats
TLM Ten Hagen et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
In situ vaccination against a non-immunogenic tumour using intratumoural injections of liposomal interleukin 2
ME Neville et al.
CYTOKINE (2001)
A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains
I Babai et al.
VACCINE (2001)
Liposome-encapsulated tumor necrosis factor-α enhances the effects of radiation against human colon tumor xenografts
DW Kim et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2001)
Neoadjuvant therapy with interleukin-12-loaded polylactic acid microspheres reduces local recurrence and distant metastases
MS Sabel et al.
SURGERY (2001)
Cytokines: Past, present, and future
JJ Oppenheim
INTERNATIONAL JOURNAL OF HEMATOLOGY (2001)
Controlled local delivery of interleukin-2 by biodegradable polymers protects animals from experimental brain tumors and liver tumors
J Hanes et al.
PHARMACEUTICAL RESEARCH (2001)
Immunoadjuvant activity of interferon-γ-liposomes co-administered with influenza vaccines
ML van Slooten et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2001)
Liposomes as sustained release system for human interferon-γ:: biopharmaceutical aspects
ML Van Slooten et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2001)
Macrophage activation for the production of immunostimulatory cytokines by delivering interleukin 1 via biodegradable microspheres
J Mullerad et al.
CYTOKINE (2000)
Protein instability in poly(lactic-co-glycolic acid) microparticles
M van de Weert et al.
PHARMACEUTICAL RESEARCH (2000)
Potential usage of thermosensitive liposomes for site-specific delivery of cytokines
Y Yuyama et al.
CANCER LETTERS (2000)
Cytokines delivered by biodegradable microspheres promote effective suppression of human tumors by human peripheral blood lymphocytes in the SCID-Winn model
NK Egilmez et al.
JOURNAL OF IMMUNOTHERAPY (2000)
Delivery of cytokines by liposomes: Hematopoietic and immunomodulatory activity of interleukin-2 encapsulated in conventional liposomes and in long-circulating liposomes
E Kedar et al.
JOURNAL OF IMMUNOTHERAPY (2000)
Liposomes containing interferon-gamma as adjuvant in tumor cell vaccines
ML van Slooten et al.
PHARMACEUTICAL RESEARCH (2000)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Share Paper
